Carisma Therapeutics, Inc. (CARM)
Carisma Therapeutics Market Cap : 1.548M for March 13, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.514B |
| Alnylam Pharmaceuticals, Inc. | 41.57B |
| Savara, Inc. | 1.068B |
| BioMarin Pharmaceutical, Inc. | 11.25B |
| Imunon, Inc. | 6.344M |
Market Cap Related Metrics
| PE Ratio | 0.1967 |
| PS Ratio | 0.0294 |
| Price | 0.037 |
| Earnings Yield | 508.4% |
| Operating PE Ratio | 0.1426 |
| Normalized PE Ratio | 0.1817 |